Sina Mahdavifard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sina Mahdavifard has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Manochehr Nakhjavani
Endocrine Division, Vali-asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
4 shared publicationsM. Nakhjavani
Endocrine Division, Vali-asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publicationsMohammad Mazani
Department of Clinical Biochemistry, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
2 shared publications- Seyedeh Zahra Bathaie
Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2 shared publications Zahra Shahi
Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
2 shared publications- Ahmad Salimi
Department of Pharmacology and Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran
1 shared publication
Latest Publications
- Retraction
- 23 October 2026
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 25 (2) , 297
Retraction Note: 1,8 cineole protects type 2 diabetic rats against diabetic nephropathy via inducing the activity of glyoxalase‑I and lowering the level of transforming growth factor‑1β
[This retracts the article DOI: 10.1007/s40200-022-01014-2.].
- 23 October 2026
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 25 (2) , 297
RetractionRetraction Note: 1,8 cineole protects type 2 diabetic rats against diabetic nephropathy via inducing the activity of glyoxalase‑I and lowering the level of transforming growth factor‑1β
[This retracts the article DOI: 10.1007/s40200-022-01014-2.].
- 22 September 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (2) , 2935-2942
Hepatoprotective effect of pyridoxal phosphate against lead poisoning by inhibiting Kupffer cell hyperplasia due to a decrease in oxidative stress associated with hepatic NF-kβ
Lead (Pb) induces tissue damage by elevating oxidative stress and activating the nuclear factor-κB (NF-κB) signaling pathway. This study aimed to investigate the effects of pyridoxal phosphate (PLP) on hepatic NF-kβ expression and endogenous antioxidant capacity. Additionally, we evaluated biochemical parameters and histological features of the liver. Forty-four rats were divided into four equal groups: a normal, an untreated lead toxicity rat model (Pbt), and two treated groups receiving PLP at of 90 mg/L and 180 mg/L in their drinking water for one month. Pb intoxication was induced by administrating of 50 mg/L of lead acetate in the drinking water over the same period. Oxidative stress and inflammatory markers were measured in serum and liver homogenates. Additionally, liver biochemical parameters, histological features, and NF-kB expression were also analyzed. PLP demonstrated a dose-dependent protective effect against Pb intoxication. Both lower and higher doses of PLP mitigated liver injury by inhibiting Kupffer cell hyperplasia, which linked to a reduction in the NF-kβ/BACT ratio and an enhancement of antioxidant capacity. The higher dose of PLP also prevented Pb-induced histopathological changes in the liver and exhibited a more pronounced positive effect on liver function. PLP exhibited a dose-dependent protective effect on the liver against Pb poisoning by inhibiting the overgrowth of Kupffer cells and reducing myeloperoxidase (MPO) activity through the regulation of hepatic NF-kB with GSH. Consequently, enhancing the GSH/GSSG ratio and stimulating antioxidant enzymes offers a promising strategy for mitigating Pb toxicity. Graphical abstract
- 22 September 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (2) , 2935-2942
Hepatoprotective effect of pyridoxal phosphate against lead poisoning by inhibiting Kupffer cell hyperplasia due to a decrease in oxidative stress associated with hepatic NF-kβ
Lead (Pb) induces tissue damage by elevating oxidative stress and activating the nuclear factor-κB (NF-κB) signaling pathway. This study aimed to investigate the effects of pyridoxal phosphate (PLP) on hepatic NF-kβ expression and endogenous antioxidant capacity. Additionally, we evaluated biochemical parameters and histological features of the liver. Forty-four rats were divided into four equal groups: a normal, an untreated lead toxicity rat model (Pbt), and two treated groups receiving PLP at of 90 mg/L and 180 mg/L in their drinking water for one month. Pb intoxication was induced by administrating of 50 mg/L of lead acetate in the drinking water over the same period. Oxidative stress and inflammatory markers were measured in serum and liver homogenates. Additionally, liver biochemical parameters, histological features, and NF-kB expression were also analyzed. PLP demonstrated a dose-dependent protective effect against Pb intoxication. Both lower and higher doses of PLP mitigated liver injury by inhibiting Kupffer cell hyperplasia, which linked to a reduction in the NF-kβ/BACT ratio and an enhancement of antioxidant capacity. The higher dose of PLP also prevented Pb-induced histopathological changes in the liver and exhibited a more pronounced positive effect on liver function. PLP exhibited a dose-dependent protective effect on the liver against Pb poisoning by inhibiting the overgrowth of Kupffer cells and reducing myeloperoxidase (MPO) activity through the regulation of hepatic NF-kB with GSH. Consequently, enhancing the GSH/GSSG ratio and stimulating antioxidant enzymes offers a promising strategy for mitigating Pb toxicity. Graphical abstract
- Open Access
- 1 January 2025
- Vol. 28 (8) , 1012-1018
Anti-obesity and hepatoprotective effects of pyridoxal phosphate in rats with metabolic syndrome by raising anti-oxidant potential in both serum and liver tissue, while also decreasing hepatic nuclear factor expression
Insulin resistance is the primary trigger of metabolic syndrome, carbonyl stress, and vitamin B6 deficiency, while the nuclear factor (NF-κB) pathway is a pivotal factor in its development. Hence, we investigated the impact of pyridoxal phosphate (PLP) on liver and kidney functions, carbonyl stress, and inflammatory markers in serum and liver tissue. The study involved four groups of rats, each consisting of eight rats: untreated normal rats (N), rats induced to have metabolic syndrome (MetS), and rats treated with PLP, labeled as N (PLP) and MetS (PLP), respectively. Metabolic syndrome was induced in rats by administering a concentrated sucrose solution for four months. The treated groups received daily PLP at 180 mg/l in their drinking water. Subsequently, the metabolic profile, NF-κB expression, indicators of gly-oxidation, inflammation, and organ function markers were evaluated. PLP significantly reduced gly-oxidation, carbonyl stress, and inflammatory indicators (in both serum and liver tissue) as well as NF-κB expression, glycation, carbonyl stress, liver fat levels, glycemia, insulin resistance, and body weight (P<0.001). The treatment also prevented acute hepatitis. PLP had beneficial effects in the metabolic syndrome rat model, showing anti-obesity and hepato-renal protective effects. It improved metabolism and organ (liver and kidney) functions by modulating NF-κB expression, glutathione metabolism, carbonyl stress, and oxidative stress.
- 1 January 2025
- Vol. 28 (8) , 1012-1018
Open AccessAnti-obesity and hepatoprotective effects of pyridoxal phosphate in rats with metabolic syndrome by raising anti-oxidant potential in both serum and liver tissue, while also decreasing hepatic nuclear factor expression
Insulin resistance is the primary trigger of metabolic syndrome, carbonyl stress, and vitamin B6 deficiency, while the nuclear factor (NF-κB) pathway is a pivotal factor in its development. Hence, we investigated the impact of pyridoxal phosphate (PLP) on liver and kidney functions, carbonyl stress, and inflammatory markers in serum and liver tissue. The study involved four groups of rats, each consisting of eight rats: untreated normal rats (N), rats induced to have metabolic syndrome (MetS), and rats treated with PLP, labeled as N (PLP) and MetS (PLP), respectively. Metabolic syndrome was induced in rats by administering a concentrated sucrose solution for four months. The treated groups received daily PLP at 180 mg/l in their drinking water. Subsequently, the metabolic profile, NF-κB expression, indicators of gly-oxidation, inflammation, and organ function markers were evaluated. PLP significantly reduced gly-oxidation, carbonyl stress, and inflammatory indicators (in both serum and liver tissue) as well as NF-κB expression, glycation, carbonyl stress, liver fat levels, glycemia, insulin resistance, and body weight (P<0.001). The treatment also prevented acute hepatitis. PLP had beneficial effects in the metabolic syndrome rat model, showing anti-obesity and hepato-renal protective effects. It improved metabolism and organ (liver and kidney) functions by modulating NF-κB expression, glutathione metabolism, carbonyl stress, and oxidative stress.
- Open Access
- 1 January 2025
- Vol. 28 (1) , 98-104
Symbiotic anti-oxidant, anti-glycation, and anti-inflammatory qualities of a combination of thiamine and niacin protected type-2 diabetic male rats against both macro and micro-vascular complications
Increased nuclear factor (NF-kβ) and carbonyl stress due to decreased glyoxalase-1 activity (Glo-I) contribute significantly to insulin resistance and vascular complications. Therefore, we aimed to study the impact of the combination of thiamine and niacin on hepatic NF-kβ signaling, metabolic profile, and Glo-I activity in male rats with type-2 diabetes (T2DM). Forty male rats were divided equally into five groups: control, diabetic, diabetic treated with thiamine (180 mg/l in drinking water), niacin (180 mg/l), and a combination of both. The treated groups received the treatments daily in drinking water for two months. T2DM was induced using a combination of nicotinamide and alloxan. Metabolic profile and renal dysfunction parameters were assessed. Additionally, various glycation, oxidative stress, and inflammatory markers were measured. The treated group with both vitamins showed the lowest blood sugar and insulin resistance indices, cardiovascular indices, renal dysfunction parameters, hepatic NF-kβ expression, oxidative stress, inflammatory and glycation markers, and the highest anti-oxidant and anti-glycation markers, β cell activity, and insulin sensitivity. Thiamine exhibited more anti-inflammatory activity than niacin in diabetic rats, while niacin demonstrated stronger anti-oxidant activity (P<0.001). The combined use of vitamins had a more beneficial impact on macro and microvascular complications in diabetes than each alone, attributed to their higher anti-oxidant, anti-inflammatory, and anti-glycation characteristics. The vitamins also had a more corrective effect on glucose-lipid metabolism, insulin sensitivity, and renal function through a stronger lowering effect on hepatic NF-kβ expression.
- 1 January 2025
- Vol. 28 (1) , 98-104
Open AccessSymbiotic anti-oxidant, anti-glycation, and anti-inflammatory qualities of a combination of thiamine and niacin protected type-2 diabetic male rats against both macro and micro-vascular complications
Increased nuclear factor (NF-kβ) and carbonyl stress due to decreased glyoxalase-1 activity (Glo-I) contribute significantly to insulin resistance and vascular complications. Therefore, we aimed to study the impact of the combination of thiamine and niacin on hepatic NF-kβ signaling, metabolic profile, and Glo-I activity in male rats with type-2 diabetes (T2DM). Forty male rats were divided equally into five groups: control, diabetic, diabetic treated with thiamine (180 mg/l in drinking water), niacin (180 mg/l), and a combination of both. The treated groups received the treatments daily in drinking water for two months. T2DM was induced using a combination of nicotinamide and alloxan. Metabolic profile and renal dysfunction parameters were assessed. Additionally, various glycation, oxidative stress, and inflammatory markers were measured. The treated group with both vitamins showed the lowest blood sugar and insulin resistance indices, cardiovascular indices, renal dysfunction parameters, hepatic NF-kβ expression, oxidative stress, inflammatory and glycation markers, and the highest anti-oxidant and anti-glycation markers, β cell activity, and insulin sensitivity. Thiamine exhibited more anti-inflammatory activity than niacin in diabetic rats, while niacin demonstrated stronger anti-oxidant activity (P<0.001). The combined use of vitamins had a more beneficial impact on macro and microvascular complications in diabetes than each alone, attributed to their higher anti-oxidant, anti-inflammatory, and anti-glycation characteristics. The vitamins also had a more corrective effect on glucose-lipid metabolism, insulin sensitivity, and renal function through a stronger lowering effect on hepatic NF-kβ expression.
- 12 December 2023
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (9) , 4047-4053
Hepatoprotective Effect of Nicotinamide Versus Lead-Motivated Hepatotoxicity in Rats via Correcting Effect on Nuclear Factor-kβ Pathway and Glutathione Metabolism
Lead (Pb) poisoning is one of the pivotal environmental issues and prompts liver dysfunction by elevating oxidative stress and inflammation. Nicotinamide (NA) deficiency enhances sensitivity to Pb toxicity. So, we investigated the effect of nicotinamide (NA) on the rat’s liver histopathological and biochemical profiles in a rat model of Pb toxicity. Thirty-six rats were divided into four groups (nine rats at each): normal (N), lead toxicity (Pbt), and NA-treated N and Pbt groups. Treated groups took NA (180 mg/L in drinking water for one month). Pb intoxication was motivated in rats by acquiring 50 mg/L lead acetate in drinking water. Oxidative stress markers (advanced oxidation protein products and malondialdehyde), antioxidant markers (total glutathione, reduced glutathione to oxidized glutathione ratio, ferric ion reducing power, catalase, and paraoxonase-1), and inflammatory markers (hepatic nuclear factor-kβ expression, interleukin 1β level, and myeloperoxidase activity) in sera and liver homogenates were determined. In addition, the biochemical parameters of the liver function were measured. Finally, the liver of rats was evaluated by histopathological observation. NA corrected lead-persuaded biochemical and histopathological changes in the rat’s liver. In addition, treatment decreased Pb, oxidative stress, and inflammatory markers in the sera and liver homogenates of N and Pbt groups. In addition, it elevated antioxidant markers (p < 0.001). NA prevented Pb-induced liver histopathological alternations and reduced liver dysfunction by reducing Pb, oxidative stress, and inflammation. Moreover, raising GSH/GSSG and diminishing the hepatic NF-kβ pathway are cardinal mechanisms of the treatment against Pb-motivated hepatotoxicity in rats.
- 12 December 2023
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (9) , 4047-4053
Hepatoprotective Effect of Nicotinamide Versus Lead-Motivated Hepatotoxicity in Rats via Correcting Effect on Nuclear Factor-kβ Pathway and Glutathione Metabolism
Lead (Pb) poisoning is one of the pivotal environmental issues and prompts liver dysfunction by elevating oxidative stress and inflammation. Nicotinamide (NA) deficiency enhances sensitivity to Pb toxicity. So, we investigated the effect of nicotinamide (NA) on the rat’s liver histopathological and biochemical profiles in a rat model of Pb toxicity. Thirty-six rats were divided into four groups (nine rats at each): normal (N), lead toxicity (Pbt), and NA-treated N and Pbt groups. Treated groups took NA (180 mg/L in drinking water for one month). Pb intoxication was motivated in rats by acquiring 50 mg/L lead acetate in drinking water. Oxidative stress markers (advanced oxidation protein products and malondialdehyde), antioxidant markers (total glutathione, reduced glutathione to oxidized glutathione ratio, ferric ion reducing power, catalase, and paraoxonase-1), and inflammatory markers (hepatic nuclear factor-kβ expression, interleukin 1β level, and myeloperoxidase activity) in sera and liver homogenates were determined. In addition, the biochemical parameters of the liver function were measured. Finally, the liver of rats was evaluated by histopathological observation. NA corrected lead-persuaded biochemical and histopathological changes in the rat’s liver. In addition, treatment decreased Pb, oxidative stress, and inflammatory markers in the sera and liver homogenates of N and Pbt groups. In addition, it elevated antioxidant markers (p < 0.001). NA prevented Pb-induced liver histopathological alternations and reduced liver dysfunction by reducing Pb, oxidative stress, and inflammation. Moreover, raising GSH/GSSG and diminishing the hepatic NF-kβ pathway are cardinal mechanisms of the treatment against Pb-motivated hepatotoxicity in rats.
- 30 September 2023
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (7) , 3141-3148
Glutamine Defended the Kidneys Versus Lead Intoxication Via Elevating Endogenous Antioxidants, Reducing Inflammation and Carbonyl Stress, as well as Improving Insulin Resistance and Dyslipidemia
Kidneys are primarily sensitive to lead (Pb) poisoning due to their cardinal role in lead excretion. Then, we studied the effect of glutamine (Gln) on lead nephrotoxicity in rats by assessing the histopathological and biochemical parameters (the renal NF-kβ expression, metabolic profile, oxidative stress, inflammatory markers, methylglyoxal (MGO), and glyoxalase-I activity). Forty rats were allotted into four groups (ten rats in each): normal (N), Gln-treated N, Pb intoxication (Pbi), and Gln-treated Pbi. The treated groups took 0.1% Gln in drinking water for 1 month. To motivate lead poisoning, rats gained 50 mg/l lead acetate in drinking water for 1 month. Oxidative stress indices (total glutathione, its reduced and oxidized forms, their ratios, advanced protein oxidation products, malondialdehyde, and ferric ion reducing power) and inflammatory markers (renal nuclear factor-kβ expression, interleukin 1β level, and myeloperoxidase activity) were measured. Furthermore, metabolic profile (fasting blood sugar, insulin, insulin resistance, lipid profile, and atherogenic index) and renal dysfunction parameters were determined. Pb-induced renal histopathological alterations were investigated by a pathologist. In the kidney of Pbi rats, the glomerulus was damaged. Gln prevented kidney damage and reduced kidney dysfunction parameters. In addition, Gln decreased oxidative stress and inflammation in sera and kidney homogenates. In addition, it improved insulin resistance, dyslipidemia, and carbonyl stress (p < 0.001). Gln guarded the kidneys versus lead intoxication by improving insulin resistance and dyslipidemia, elevating antioxidant markers, and diminishing inflammation and carbonyl stress.
- 30 September 2023
- Published by Springer Nature in Biological Trace Element Research
- Vol. 202 (7) , 3141-3148
Glutamine Defended the Kidneys Versus Lead Intoxication Via Elevating Endogenous Antioxidants, Reducing Inflammation and Carbonyl Stress, as well as Improving Insulin Resistance and Dyslipidemia
Kidneys are primarily sensitive to lead (Pb) poisoning due to their cardinal role in lead excretion. Then, we studied the effect of glutamine (Gln) on lead nephrotoxicity in rats by assessing the histopathological and biochemical parameters (the renal NF-kβ expression, metabolic profile, oxidative stress, inflammatory markers, methylglyoxal (MGO), and glyoxalase-I activity). Forty rats were allotted into four groups (ten rats in each): normal (N), Gln-treated N, Pb intoxication (Pbi), and Gln-treated Pbi. The treated groups took 0.1% Gln in drinking water for 1 month. To motivate lead poisoning, rats gained 50 mg/l lead acetate in drinking water for 1 month. Oxidative stress indices (total glutathione, its reduced and oxidized forms, their ratios, advanced protein oxidation products, malondialdehyde, and ferric ion reducing power) and inflammatory markers (renal nuclear factor-kβ expression, interleukin 1β level, and myeloperoxidase activity) were measured. Furthermore, metabolic profile (fasting blood sugar, insulin, insulin resistance, lipid profile, and atherogenic index) and renal dysfunction parameters were determined. Pb-induced renal histopathological alterations were investigated by a pathologist. In the kidney of Pbi rats, the glomerulus was damaged. Gln prevented kidney damage and reduced kidney dysfunction parameters. In addition, Gln decreased oxidative stress and inflammation in sera and kidney homogenates. In addition, it improved insulin resistance, dyslipidemia, and carbonyl stress (p < 0.001). Gln guarded the kidneys versus lead intoxication by improving insulin resistance and dyslipidemia, elevating antioxidant markers, and diminishing inflammation and carbonyl stress.
- 9 September 2023
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 58, 61-66
Crocetin ameliorative effect on diabetic nephropathy in rats through a decrease in transforming growth factor-β and an increase in glyoxalase-I activity
- 9 September 2023
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 58, 61-66
Crocetin ameliorative effect on diabetic nephropathy in rats through a decrease in transforming growth factor-β and an increase in glyoxalase-I activity
- Open Access
- 5 July 2023
- Published by Springer Nature in Research Square
Hepatoprotective effect of nicotinamide versus lead-motivated hepatotoxicity in rats via correcting effect on nuclear factor-kβ pathway and glutathione metabolism
Objective(s): Many years ago, until now, lead (Pb) poisoning is one of the pivotal environmental issues. Pb prompts liver dysfunction by elevating inflammation following oxidative stress. Consequently, we for the first time investigated the effect of nicotinamide (B3) on the rat's liver histopathological and biochemical profiles in a rat model of Pb toxicity. Materials and Methods Thirty-six rats were shared into four groups (nine rats in each): untreated normal (N), B3 treated normal (N-B3), lead toxicity (Pbt), and B3 lead toxicity (Pbt-B3). Treated groups took B3 (180 mg/L in drinking water for one month). Pb intoxication was motivated in rats by acquiring 50 mg/l lead acetate from drinking water. Oxidative stress markers (advanced protein oxidation products, and malondialdehyde), antioxidant markers (total glutathione, reduced (GSH) to oxidized (GSSG) glutathione ratio, ferric ion reducing power, catalase, and paraoxonase-1), and inflammatory markers (hepatic nuclear factor-kβ expression, interleukin 1β level, and myeloperoxidase activity) in sera and liver homogenates were determined. Further, Biochemical liver function indicators (Alanine transaminase, aspartate transaminase, alkaline phosphatase, gamma-glutamyl transpeptidase, total bilirubin, total protein, albumin, and globulins) were quantified. Pb-induced liver damage was assessed with Histopathological observation. Results: B3 corrected lead-persuaded biochemical and histopathological changes in the rat's liver. In addition, treatment diminished Pb, oxidative stress, and inflammatory markers in the sera and liver homogenates of N-B3 and Pbt-B3 groups as well as elevated antioxidant markers (p < 0.001). Conclusions Nicotinamide through a decrease in Pb, oxidative stress, and inflammation prevented Pb prompted liver histopathological alternations and reduced liver dysfunction parameters.
- 5 July 2023
- Published by Springer Nature in Research Square
Open AccessHepatoprotective effect of nicotinamide versus lead-motivated hepatotoxicity in rats via correcting effect on nuclear factor-kβ pathway and glutathione metabolism
Objective(s): Many years ago, until now, lead (Pb) poisoning is one of the pivotal environmental issues. Pb prompts liver dysfunction by elevating inflammation following oxidative stress. Consequently, we for the first time investigated the effect of nicotinamide (B3) on the rat's liver histopathological and biochemical profiles in a rat model of Pb toxicity. Materials and Methods Thirty-six rats were shared into four groups (nine rats in each): untreated normal (N), B3 treated normal (N-B3), lead toxicity (Pbt), and B3 lead toxicity (Pbt-B3). Treated groups took B3 (180 mg/L in drinking water for one month). Pb intoxication was motivated in rats by acquiring 50 mg/l lead acetate from drinking water. Oxidative stress markers (advanced protein oxidation products, and malondialdehyde), antioxidant markers (total glutathione, reduced (GSH) to oxidized (GSSG) glutathione ratio, ferric ion reducing power, catalase, and paraoxonase-1), and inflammatory markers (hepatic nuclear factor-kβ expression, interleukin 1β level, and myeloperoxidase activity) in sera and liver homogenates were determined. Further, Biochemical liver function indicators (Alanine transaminase, aspartate transaminase, alkaline phosphatase, gamma-glutamyl transpeptidase, total bilirubin, total protein, albumin, and globulins) were quantified. Pb-induced liver damage was assessed with Histopathological observation. Results: B3 corrected lead-persuaded biochemical and histopathological changes in the rat's liver. In addition, treatment diminished Pb, oxidative stress, and inflammatory markers in the sera and liver homogenates of N-B3 and Pbt-B3 groups as well as elevated antioxidant markers (p < 0.001). Conclusions Nicotinamide through a decrease in Pb, oxidative stress, and inflammation prevented Pb prompted liver histopathological alternations and reduced liver dysfunction parameters.
- 16 July 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 21 (2) , 1233-1240
Protective effect of acetylcysteine, histidine, and their combination against diabetes vascular complications in type-2 diabetic rats via reducing NF-kβ pathway signaling
Purpose The nuclear factor-kappa B (NF-κB) signaling participates in diabetes complications. Therefore, the reduction of NF-κB signaling may be a goal to prevent or improve them. Thus, we investigated the effects of acetylcysteine (AC), histidine (His), and their combination on the NF-κB expression and its different activators in type 2 diabetic rats. Methods The survey was performed on 50 rats that were allotted equally into five groups composed of control, diabetic, diabetic treated with (AC, 0.06%), (His, 0.1%), and (AC & His) groups. Treated groups have received the treatments daily in drinking water for two months. Metabolic profile (glucose, insulin resistance indices, lipid profile, and cardiovascular indices) and renal dysfunction parameters (creatinine and urinary protein excretion) were measured. Plus, diverse glycation (early, intermediate, and end), oxidative stress (Oxidized LDL, Reduced glutathione), and inflammatory markers (interleukine-1β, myeloperoxidase, and NF-kβ expression) were determined. Results Glucose, insulin resistance indices, cardiovascular indices, renal dysfunction parameters, different markers of glycation, oxidative stress, and inflammation as well as NF-κB expression, were the lowest in the (AC & His) treated diabetic rats. Besides, the cited parameter was lower in the Ac treated one than His treated (p > 0.001). Conclusion The combination of AC and His had the most protective effect against diabetes complications and advantageous effect on metabolism, β-cell activity, and insulin function due to the most reductive effect on the NF-κB pathway rather than More than any of the amino acids alone.
- 16 July 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 21 (2) , 1233-1240
Protective effect of acetylcysteine, histidine, and their combination against diabetes vascular complications in type-2 diabetic rats via reducing NF-kβ pathway signaling
Purpose The nuclear factor-kappa B (NF-κB) signaling participates in diabetes complications. Therefore, the reduction of NF-κB signaling may be a goal to prevent or improve them. Thus, we investigated the effects of acetylcysteine (AC), histidine (His), and their combination on the NF-κB expression and its different activators in type 2 diabetic rats. Methods The survey was performed on 50 rats that were allotted equally into five groups composed of control, diabetic, diabetic treated with (AC, 0.06%), (His, 0.1%), and (AC & His) groups. Treated groups have received the treatments daily in drinking water for two months. Metabolic profile (glucose, insulin resistance indices, lipid profile, and cardiovascular indices) and renal dysfunction parameters (creatinine and urinary protein excretion) were measured. Plus, diverse glycation (early, intermediate, and end), oxidative stress (Oxidized LDL, Reduced glutathione), and inflammatory markers (interleukine-1β, myeloperoxidase, and NF-kβ expression) were determined. Results Glucose, insulin resistance indices, cardiovascular indices, renal dysfunction parameters, different markers of glycation, oxidative stress, and inflammation as well as NF-κB expression, were the lowest in the (AC & His) treated diabetic rats. Besides, the cited parameter was lower in the Ac treated one than His treated (p > 0.001). Conclusion The combination of AC and His had the most protective effect against diabetes complications and advantageous effect on metabolism, β-cell activity, and insulin function due to the most reductive effect on the NF-κB pathway rather than More than any of the amino acids alone.